Anshumaan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 05-11-2024
- Paid Up Capital ₹ 0.10 M
as on 05-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 05-11-2024
- Revenue 24.84%
(FY 2023)
- Profit 76.14%
(FY 2023)
- Ebitda 0.30%
(FY 2023)
- Net Worth 80.84%
(FY 2023)
- Total Assets -21.18%
(FY 2023)
About Anshumaan Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Babu Chittiboina and Bali Gopireddy serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC142397
- Company No.
142397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anshumaan Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babu Chittiboina  | Director | 01-Aug-2020 | Current |
| Bali Gopireddy | Director | 01-Aug-2020 | Current |
Financial Performance of Anshumaan Laboratories.
Anshumaan Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.84% increase. The company also saw a substantial improvement in profitability, with a 76.14% increase in profit. The company's net worth Soared by an impressive increase of 80.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anshumaan Laboratories?
Unlock access to Anshumaan Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Arrow Engineering Industries Private LimitedActive 5 years 2 monthsBabu Chittiboina and Bali Gopireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Apr 2024 | ₹4.00 M | Open |
Bank Of India Creation Date: 15 Nov 2021 | ₹1.00 M | Open |
How Many Employees Work at Anshumaan Laboratories?
Anshumaan Laboratories has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anshumaan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anshumaan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
